The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat

Neurobiology of Disease

Volumn 22, Issue 2, 2006, Pages 334-345

  Lane, E L ^a   Winkler, C ^b   Brundin, P ^a   Cenci, M A ^a  

^a LUND UNIVERSITY   (Sweden)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Amphetamine; Graft induced dyskinesia; Parkinson's disease; Transplantation

Indexed keywords

AMPHETAMINE; LEVODOPA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DYSKINESIA; EVOKED RESPONSE; FEMALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SEROTONIN UPTAKE;

AMPHETAMINE; ANIMALS; BRAIN TISSUE TRANSPLANTATION; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGENTS; DOPAMINE UPTAKE INHIBITORS; DYSKINESIA, DRUG-INDUCED; FEMALE; LEVODOPA; MOVEMENT; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; SEROTONIN UPTAKE INHIBITORS; SUBSTANTIA NIGRA; TRANSPLANTATION TOLERANCE;

EID: 33646140789     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.11.011     Document Type: Article

References (47)

1. Abercrombie U. Estimation of nuclear populations from microtome sections. Brain Res. 94 (1946) 239-247
2. Andersson M., Hilbertson A., and Cenci M.A. Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. Neurobiol. Dis. 6 6 (1999) 461-474
3. Aubert I., Guigoni C., Hakansson K., Li Q., Dovero S., Barthe N., Bioulac B.H., Gross C.E., Fisone G., Bloch B., and Bezard E. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann. Neurol. 57 1 (2005) 17-26
4. Bartlett L.E., Sadi D., Lewington M., and Mendez I. Functional improvement with low-dose dopaminergic grafts in hemiparkinsonian rats. Neurosurgery 55 2 (2004) 405-412 (discussion 412-5)
5. Björklund A. Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr. Opin. Neurobiol. 2 (1992) 683-689
6. Björklund A., Dunnett S.B., Stenevi U., Lewis M.E., and Iversen S.D. Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 199 (1980) 307-333
7. Brundin P., Karlsson J., Emgard M., Schierle G.S., Hansson O., Petersen A., and Castilho R.F. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. 9 2 (2000) 179-195
8. Cenci M.A., and Bjorklund A. Transection of corticostriatal afferents abolishes the hyperexpression of Fos and counteracts the development of rotational overcompensation induced by intrastriatal dopamine-rich grafts when challenged with amphetamine. Brain Res. 665 1 (1994) 167-174
9. Cenci M.A., and Hagell P. Dyskinesia and neural grafting in Parkinson's disease. In: Brundin P., and Olanow C.W. (Eds). Restorative Therapies in Parkinson's Disease (2005), Kluver Academic/Plenum Publishers, New York, NY
10. Cenci M.A., Kalen P., Mandel R.J., Wictorin K., and Bjorklund A. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Neuroscience 46 4 (1992) 943-957
11. Cenci M.A., Lee C.S., and Bjorklund A. l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur. J. Neurosci. 10 8 (1998) 2694-2706
12. Cenci M.A., Whishaw I.Q., and Schallert T. Animal models of neurological deficits: how relevant is the rat?. Nat. Rev., Neurosci. 3 7 (2002) 574-579
13. Chritin M., Savasta M., Mennicken F., Bal A., Abrous D.N., Le Moal M., Feuerstein C., and Herman J.P. Intrastriatal dopamine-rich implants reverse the increase of dopamine D2 receptor mRNA levels caused by lesion of the nigrostriatal pathway: a quantitative in situ hybridization study. Eur. J. Neurosci. 4 7 (1992) 663-672
14. Cochen V., Ribeiro M.J., Nguyen J.P., Gurruchaga J.M., Villafane G., Loc'h C., Defer G., Samson Y., Peschanski M., Hantraye P., Cesaro P., and Remy P. Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue. Mov. Disord. 18 8 (2003) 928-932
15. Date I., Asari S., and Ohmoto T. Two-year follow-up study of a patient with Parkinson's disease and severe motor fluctuations treated by co-grafts of adrenal medulla and peripheral nerve into bilateral caudate nuclei: case report. Neurosurgery 37 3 (1995) 515-518 (discussion 518-9)
16. Dawson T.M., Dawson V.L., Gage F.H., Fisher L.J., Hunt M.A., and Warmsley J.K. Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra. Exp. Neurol. 111 (1991) 282-292
17. Defer G.L., Geny C., Ricolfi F., Fenelon G., Monfort J.C., Remy P., Villafane G., Jeny R., Samson Y., Keravel Y., Gaston A., Degos J.D., Peschanski M., Cesaro P., and Nguyen J.P. Long-term outcome of unilaterally transplanted parkinsonian patients: I. Clinical approach. Brain 119 Pt. 1 (1996) 41-50
18. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann. N. Y. Acad. Sci. 991 (2003) 1-14
19. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., and Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344 10 (2001) 710-719
20. Hagell P., Piccini P., Bjorklund A., Brundin P., Rehncrona S., Widner H., Crabb L., Pavese N., Oertel W.H., Quinn N., Brooks D.J., and Lindvall O. Dyskinesias following neural transplantation in Parkinson's disease. Nat. Neurosci. 5 7 (2002) 627-628
21. Hauser R.A., Freeman T.B., Snow B.J., Nauert M., Gauger L., Kordower J.H., and Olanow C.W. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol. 56 2 (1999) 179-187
22. Herman J.P., Rouge-Pont F., Le Moal M., and Abrous D.N. Mechanisms of amphetamine-induced rotation in rats with unilateral intrastriatal grafts of embryonic dopaminergic neurons: a pharmacological and biochemical analysis. Neuroscience 53 4 (1993) 1083-1095
23. Kopyov O.V., Jacques D., Lieberman A., Duma C.M., and Rogers R.L. Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease. Cell Transplant. 5 2 (1996) 327-337
24. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J., Mufson E.J., Sanberg P.R., Hauser R.A., Smith D.A., Nauert G.M., Perl D.P., et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332 17 (1995) 1118-1124
25. Lane E.L., Cheetham S., and Jenner P. Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors. J. Pharmacol. Exp. Ther. 312 3 (2005) 1124-1131
26. Lee C.S., Cenci M.A., Schulzer M., and Bjorklund A. Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain 123 Pt. 7 (2000) 1365-1379
27. Lindvall O., Sawle G., Widner H., Rothwell J.C., Bjorklund A., Brooks D., Brundin P., Frackowiak R., Marsden C.D., Odin P., et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35 2 (1994) 172-180
28. Lundblad M., Andersson M., Winkler C., Kirik D., Wierup N., and Cenci M.A. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur. J. Neurosci. 15 1 (2002) 120-132
29. Luquin M.R., Scipioni O., Vaamonde J., Gershanik O., and Obeso J.A. Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. Mov. Disord. 7 2 (1992) 117-124
30. Ma Y., Feigin A., Dhawan V., Fukuda M., Shi Q., Greene P., Breeze R., Fahn S., Freed C., and Eidelberg D. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann. Neurol. 52 5 (2002) 628-634
31. Maries E., Collier T.J., Olaru E., Sortwell C.E., Shannon K.M., Kordower J.H., and Steece-Collier K. Correlation of Graft-derived Reinnervation with Post-graft Dyskinesia Occurrence in a Rat Model of Parkinson's Disease (2003), Society for Neuroscience, New Orleans
32. Maries, E., Kordower, J.H., Chu, Y., Collier, T.J., Sortwell, C.E., Olaru, E., Shannon, K., Steece-Collier, K., in press. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol. Dis.
33. Mendez, I., Sanchez-Pernaute, R., Cooper, O., Vinuela, A., Ferrari, D., Bjorklund, L., Dagher, A., Isacson, O., in press. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain.
34. Morrish P.K., Sawle G.V., and Brooks D.J. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 119 Pt. 2 (1996) 585-591
35. Munoz A., Rodriguez-Pallares J., Guerra M.J., and Labandeira-Garcia J.L. Host brain regulation of dopaminergic grafts function: role of the serotonergic and noradrenergic systems in amphetamine-induced responses. Synapse 47 1 (2003) 66-76
36. Nakao N., Frodl E.M., Duan W.M., Widner H., and Brundin P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. U. S. A. 91 26 (1994) 12408-12412
37. Nutt J.G. Dyskinesia induced by levodopa and dopamine agonists in patients with Parkinson's disease. In: Lang A.E., and Weiner W.J. (Eds). Drug-Induced Movement Disorders (1992), Futura Publishing Co., Mount Kisko 281-314
38. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., Shannon K.M., Nauert G.M., Perl D.P., Godbold J., and Freeman T.B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54 3 (2003) 403-414
39. Olanow C.W., Agid Y., Mizuno Y., Albanese A., Bonucelli U., Damier P., De Yebenes J., Gershanik O., Guttman M., Grandas F., Hallett M., Hornykiewicz O., Jenner P., Katzenschlager R., Langston W.J., LeWitt P., Melamed E., Mena M.A., Michel P.P., Mytilineou C., Obeso J.A., Poewe W., Quinn N., Raisman-Vozari R., Rajput A.H., Rascol O., Sampaio C., and Stocchi F. Levodopa in the treatment of Parkinson's disease: current controversies. Mov. Disord. 19 9 (2004) 997-1005
40. Picconi B., Centonze D., Hakansson K., Bernardi G., Greengard P., Fisone G., Cenci M.A., and Calabresi P. Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia. Nat. Neurosci. 6 5 (2003) 501-506
41. Schallert T., and Tillerson J.L. Intervention strategies for degeneration of dopamine neurons in parkinsonism: optimizing behavioral assessment of outcome. In: Emerich D.F., Dean III R.L., and Sanberg P.R. (Eds). Central Nervous System Diseases: Innovative Models of CNS Diseases From Molecule to Therapy (2000), Totowa, NJ, Humana 131-151
42. Steece-Collier K., Collier T.J., Danielson P.D., Kurlan R., Yurek D.M., and Sladek Jr. J.R. Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats. Mov. Disord. 18 12 (2003) 1442-1454
43. Stromberg I., Kehr J., Andbjer B., and Fuxe K. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum. Exp. Neurol. 164 1 (2000) 154-165
44. West M.J., Slomianka L., and Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231 4 (1991) 482-497
45. Winkler C., Kirik D., and Bjorklund A. Cell transplantation in Parkinson's disease: how can we make it work?. Trends Neurosci. 28 2 (2005) 86-92
46. Zetterstrom T., Brundin P., Gage F.H., Sharp T., Isacson O., Dunnett S.B., Ungerstedt U., and Björklund A. In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral microdialysis. Brain Res. 362 (1986) 344-349
47. Zetterstrom T., Herrera-Marschitz M., and Ungerstedt U. Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis. Brain Res. 376 1 (1986) 1-7